Getinge (OTCMKTS:GNGBY) Trading Up 9.2% – Still a Buy?

Getinge (OTCMKTS:GNGBY) was up 9.2% during mid-day trading on Monday . The company traded as high as $23.70 and last traded at $23.70. Approximately 111 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 3,449 shares. The stock had previously closed at $21.70.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded Getinge to a “hold” rating in a research report on Thursday, April 23rd. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Getinge Stock Performance

The firm has a market capitalization of $6.51 billion, a price-to-earnings ratio of 22.77 and a beta of 0.96. The firm has a 50 day moving average price of $20.78 and a 200-day moving average price of $21.33. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.32 and a quick ratio of 0.86.

Getinge (OTCMKTS:GNGBY) last released its earnings results on Friday, July 17th. The company reported $0.38 EPS for the quarter. Getinge had a return on equity of 11.67% and a net margin of 7.81%.The firm had revenue of $894.87 million during the quarter. As a group, sell-side analysts expect that Getinge will post 1.33 earnings per share for the current fiscal year.

Getinge Company Profile

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.